Canada· CA-DIN-00176206
FIORINAL-C 1/2
A codein, kombinationen mit psycholeptika (codein monopräparate siehe r05da04) product containing acetylsalicylic acid + codeine phosphate + caffeine + butalbital, registered in Canada by ARALEZ PHARMACEUTICALS CANADA INC. The same ATC class is registered in 2 of our 19 countries.
Checked against Health Canada Drug Product Database (Canada) on
Informational only — not a medical device.
Where it is registered
Codein, kombinationen mit psycholeptika (codein monopräparate siehe r05da04) is registered in 2 of 19 countries.
Countries holding a registration under ATC N02AA79 (codein, kombinationen mit psycholeptika (codein monopräparate siehe r05da04)), each read from that country’s own register.
- This record: Canada, from Health Canada Drug Product Database (Canada)
- 1 of them publish a price we can compare per daily dose
Codein, kombinationen mit psycholeptika (codein monopräparate siehe r05da04) · ATC N02AA79
2 / 19 countries
- Belgiumprice
- Canada
The record
At a glance
Health Canada Drug Product Database (Canada)- Active substance
- ACETYLSALICYLIC ACID + CODEINE PHOSPHATE + CAFFEINE + BUTALBITAL
- Manufacturer
- ARALEZ PHARMACEUTICALS CANADA INC
- Country
- Canada (CA)
- ATC code
- N02AA79
- ATC class
- Codein, Kombinationen mit Psycholeptika (Codein Monopräparate siehe R05DA04)
- Reimbursed
- Not published by this register
- Source register
- Health Canada Drug Product Database (Canada)
- Last checked
- October 1, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
2 interactions on record for codein, kombinationen mit psycholeptika (codein monopräparate siehe r05da04).
Mechanism, severity and management for each pair, from a commercially licensed source — included with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Codein, kombinationen mit psycholeptika (codein monopräparate siehe r05da04) · interactions on record
2 records
2 more interactions with mechanism and management, from a commercially licensed source.
Sign in to checkSame medicine, other countries
Codein, kombinationen mit psycholeptika (codein monopräparate siehe r05da04) in 1 other country
What each register calls a product with the same active substance — salts and hydrates count as the same.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Health Canada Drug Product Database (Canada). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/684ee212-fceb-4b1a-b319-5d9bb800a875 GET /v1/drugs/684ee212-fceb-4b1a-b319-5d9bb800a875?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"din": "00176206",
"form": "CAPSULE",
"class": "Human",
"routes": [
"ORAL"
],
"source": "health_canada_dpd",
"status": "MARKETED",
"atc_raw": "N02AA79",
"schedule": [
"Narcotic (CDSA I)"
],
"drug_code": "873",
"strengths": [
"330 MG",
"30 MG",
"40 MG",
"50 MG"
],
"ahfs_class": null,
"substances": [
"ACETYLSALICYLIC ACID",
"CODEINE PHOSPHATE",
"CAFFEINE",
"BUTALBITAL"
],
"product_categorization": null
}See everything about codein, kombinationen mit psycholeptika (codein monopräparate siehe r05da04).
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.